These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 31402200

  • 21. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 22. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R, Julian BA, Konecny K, Mestecky J.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [Abstract] [Full Text] [Related]

  • 23. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.
    Novak J, Julian BA, Tomana M, Mestecky J.
    Semin Nephrol; 2008 Jan; 28(1):78-87. PubMed ID: 18222349
    [Abstract] [Full Text] [Related]

  • 24. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
    Reily C, Ueda H, Huang ZQ, Mestecky J, Julian BA, Willey CD, Novak J.
    J Immunol Res; 2014 Jan; 2014():197548. PubMed ID: 25152896
    [Abstract] [Full Text] [Related]

  • 25. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 26. LPS/TLR4 Pathway Regulates IgA1 Secretion to Induce IgA Nephropathy.
    He H, Shen M, Tang Y, Sun W, Xu X.
    Altern Ther Health Med; 2024 Jan; 30(1):419-425. PubMed ID: 37820669
    [Abstract] [Full Text] [Related]

  • 27. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
    Elíasdóttir S, Khramova A, Saeed A, Guron G, Boi R, Mölne J, Ebefors K, Nyström J.
    BMC Nephrol; 2023 Jun 07; 24(1):160. PubMed ID: 37286948
    [Abstract] [Full Text] [Related]

  • 28. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC.
    Nefrologia; 2005 Jun 07; 25 Suppl 2():82-6. PubMed ID: 16050408
    [Abstract] [Full Text] [Related]

  • 29. Immunopathogenesis of IgAN.
    Barratt J, Smith AC, Molyneux K, Feehally J.
    Semin Immunopathol; 2007 Nov 07; 29(4):427-43. PubMed ID: 17851660
    [Abstract] [Full Text] [Related]

  • 30. IgA production and tonsillar focal infection in IgA nephropathy.
    Meng H, Ohtake H, Ishida A, Ohta N, Kakehata S, Yamakawa M.
    J Clin Exp Hematop; 2012 Nov 07; 52(3):161-70. PubMed ID: 23269075
    [Abstract] [Full Text] [Related]

  • 31. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
    Chen P, Shi SF, Qu Z, Zhao N, Xie XF, Lv JC, Liu LJ, Zhang H.
    Ren Fail; 2018 Nov 07; 40(1):213-218. PubMed ID: 29619862
    [Abstract] [Full Text] [Related]

  • 32. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y.
    Clin Transplant; 2005 Nov 07; 19 Suppl 14():41-8. PubMed ID: 15955168
    [Abstract] [Full Text] [Related]

  • 33. IgA nephropathy: current views of immune complex formation.
    Mestecky J, Suzuki H, Yanagihara T, Moldoveanu Z, Tomana M, Matousovic K, Julian BA, Novak J.
    Contrib Nephrol; 2007 Nov 07; 157():56-63. PubMed ID: 17495438
    [Abstract] [Full Text] [Related]

  • 34. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
    Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J.
    J Clin Invest; 1999 Jul 07; 104(1):73-81. PubMed ID: 10393701
    [Abstract] [Full Text] [Related]

  • 35. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Jul 07; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 36. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y.
    Kidney Int; 2018 Mar 07; 93(3):700-705. PubMed ID: 29329643
    [Abstract] [Full Text] [Related]

  • 37. Follicular Helper T Cells in Peyer's Patches and Galactose- Deficient Iga1 Contribute to Iga Nephropathy.
    Huang Y, Sun X, Nie G, Xu H, Zou M.
    Curr Mol Med; 2024 Mar 07; 24(8):1033-1044. PubMed ID: 37475555
    [Abstract] [Full Text] [Related]

  • 38. [Role of IgG antibody to galactose-deficient IgA1 in children with IgA nephropathy].
    Zhou N, Zhang H, Liu XR, Sun Q, Meng Q, Chen Z, Shen Y.
    Zhonghua Er Ke Za Zhi; 2017 Sep 02; 55(9):663-667. PubMed ID: 28881511
    [Abstract] [Full Text] [Related]

  • 39. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T.
    PLoS One; 2018 Sep 02; 13(11):e0206865. PubMed ID: 30388165
    [Abstract] [Full Text] [Related]

  • 40. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep 02; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.